<DOC>
	<DOCNO>NCT00291499</DOCNO>
	<brief_summary>The goal present study investigate effectiveness Condrosulf速 800 mg tablet vs. placebo day 6 month symptomatic treatment finger joint osteoarthritis . Primary endpoint study evaluation global spontaneous pain ( Huskisson 's Visual Analogue Scale : VAS ) score Dreiser 's algo-functional index ( FIHOA ) treatment tested product , Condrosulf速 , versus placebo .</brief_summary>
	<brief_title>Efficacy Study Condrosulf Treatment Symptomatic OA Hand</brief_title>
	<detailed_description>The goal present study investigate effectiveness Condrosulf速 800 mg tablet vs. placebo day 6 month symptomatic treatment finger joint osteoarthritis 160 randomised patient . Primary endpoint : Primary endpoint study evaluation global spontaneous pain ( Huskisson 's Visual Analogue Scale : VAS ) score Dreiser 's algo-functional index ( FIHOA ) treatment tested product , Condrosulf速 , versus placebo . Secondary endpoint : Efficacy evaluation : Global impression efficacy express patient physician ( VAS ) , Grip strength ( measure manometrically ) ; Morning stiffness duration ; Consumption Paracetamol ; Tolerability ( 4-point verbal scale ) ; Adverse Events occur treatment period ; Other parameter : Treatment compliance ; Biological marker arthritis</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients either sex Aged 40 Outpatients Patients fulfil ACR criterion report hand OA Patients show Xray feature hand OA least two joint ( 2 IP and/or 1 IP 1 TMC ) dominant hand standard plain radiograph ( &lt; 6 month ) . Suffering regular spontaneous pain dominant hand ( VAS &gt; = 40 mm inclusion time ) . Showing FIHOA score &gt; = 6 . Having least two painful flare finger joint previous 12 month . Patients sign write informed consent participation study Patients able understand follow protocol . Patients satisfy health nutritional status . Female subject childbearing potential use , within three month prior inclusion study , reliable form contraception course study ( oral contraceptive pill , intrauterine device condom ) female non childbearing potential ( hysterectomy , bilateral ovariectomy tubal section/ligation ) . Female subject childbearing potential negative urinary pregnancy test inclusion study . Inflammatory joint disease origin Septic arthritis Chronic inflammatory joint disease Previous articular fracture concern articulation Use analgesic therapy indication Receiving oral corticosteroid Monoarticular posttraumatic OA finger Planning surgery hand follow 6 month Patients suffer suffer secondary osteoarthritis one following disease : Infectious arthritis Acromegaly Ochronosis Hemachromatosis Gout Wilson 's disease Chondrocalcinosis Paget 's disease Osteochondrosis Mutation collagen Genetic problem ( ex . hypermobility ) Previous joint fracture Arthropathies different aetiology Algodystrophy ( M. Sudeck ) Congenital abnormalities Recurrent pseudogout Major displasias Intraarticular injection hand joint le 3 month Basic treatment arthritis symptommodifying agent ( chondroitin sulfate , glucosamine sulfate , diacerrhein , hyaluronic acid ) last 3 month Articular lavage last 3 month Treatment corticoid , administration route last month Patient suffer frequent asthma crisis Physiotherapy , reeducation , alternative medicine ( mesotherapy , acupuncture ) hand foreseeable next year Serious organic disease : heart failure , renal hepatic insufficiency , blood dyscrasia , serious infection Participation clinical trial two month precede study Known ascertain hypersensitivity active ingredient test drug . Patients refuse sign write informed consent form Patients cooperate , respect protocol requirement Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>symptomatic OA hand</keyword>
</DOC>